Privia Health Group (PRVA) Competitors

Privia Health Group logo
$25.24 -0.02 (-0.08%)
As of 02:10 PM Eastern
This is a fair market value price provided by Massive. Learn more.

PRVA vs. FMS, DVA, HNGE, CHE, and RDNT

Should you buy Privia Health Group stock or one of its competitors? Privia Health Group's main competitors and comparable companies include Fresenius Medical Care AG & Co. KGaA (FMS), DaVita (DVA), Hinge Health (HNGE), Chemed (CHE), and RadNet (RDNT). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does Privia Health Group compare to Fresenius Medical Care AG & Co. KGaA?

Privia Health Group (NASDAQ:PRVA) and Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their media sentiment, analyst recommendations, earnings, dividends, profitability, institutional ownership, risk and valuation.

Privia Health Group presently has a consensus price target of $31.20, indicating a potential upside of 23.52%. Fresenius Medical Care AG & Co. KGaA has a consensus price target of $23.43, indicating a potential upside of 7.22%. Given Privia Health Group's stronger consensus rating and higher possible upside, analysts plainly believe Privia Health Group is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Fresenius Medical Care AG & Co. KGaA
5 Sell rating(s)
7 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
1.58

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than Privia Health Group. Fresenius Medical Care AG & Co. KGaA is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$2.12B1.52$22.92M$0.2697.15
Fresenius Medical Care AG & Co. KGaA$22.20B0.52$1.11B$1.7312.63

94.5% of Privia Health Group shares are held by institutional investors. Comparatively, 8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. 5.7% of Privia Health Group shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.23% compared to Privia Health Group's net margin of 1.43%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.08% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group1.43% 4.20% 2.38%
Fresenius Medical Care AG & Co. KGaA 4.23%9.08%4.04%

In the previous week, Fresenius Medical Care AG & Co. KGaA had 3 more articles in the media than Privia Health Group. MarketBeat recorded 8 mentions for Fresenius Medical Care AG & Co. KGaA and 5 mentions for Privia Health Group. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 0.92 beat Privia Health Group's score of 0.83 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Fresenius Medical Care AG & Co. KGaA
8 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Privia Health Group has a beta of 0.76, indicating that its stock price is 24% less volatile than the broader market. Comparatively, Fresenius Medical Care AG & Co. KGaA has a beta of 0.78, indicating that its stock price is 22% less volatile than the broader market.

Summary

Fresenius Medical Care AG & Co. KGaA beats Privia Health Group on 9 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to DaVita?

DaVita (NYSE:DVA) and Privia Health Group (NASDAQ:PRVA) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends.

DaVita has a beta of 0.87, meaning that its stock price is 13% less volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market.

90.1% of DaVita shares are owned by institutional investors. Comparatively, 94.5% of Privia Health Group shares are owned by institutional investors. 1.9% of DaVita shares are owned by company insiders. Comparatively, 5.7% of Privia Health Group shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

DaVita has higher revenue and earnings than Privia Health Group. DaVita is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
DaVita$13.64B0.80$746.80M$13.5812.80
Privia Health Group$2.12B1.52$22.92M$0.2697.15

DaVita presently has a consensus target price of $235.86, suggesting a potential upside of 35.69%. Privia Health Group has a consensus target price of $31.20, suggesting a potential upside of 23.52%. Given DaVita's higher probable upside, research analysts plainly believe DaVita is more favorable than Privia Health Group.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
DaVita
0 Sell rating(s)
3 Hold rating(s)
4 Buy rating(s)
0 Strong Buy rating(s)
2.57
Privia Health Group
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

DaVita has a net margin of 6.49% compared to Privia Health Group's net margin of 1.43%. Privia Health Group's return on equity of 4.20% beat DaVita's return on equity.

Company Net Margins Return on Equity Return on Assets
DaVita6.49% -225.93% 5.42%
Privia Health Group 1.43%4.20%2.38%

In the previous week, DaVita had 8 more articles in the media than Privia Health Group. MarketBeat recorded 13 mentions for DaVita and 5 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.83 beat DaVita's score of 0.46 indicating that Privia Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
DaVita
4 Very Positive mention(s)
1 Positive mention(s)
7 Neutral mention(s)
1 Negative mention(s)
0 Very Negative mention(s)
Neutral
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

DaVita and Privia Health Group tied by winning 8 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to Hinge Health?

Privia Health Group (NASDAQ:PRVA) and Hinge Health (NYSE:HNGE) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their institutional ownership, earnings, media sentiment, valuation, analyst recommendations, risk, dividends and profitability.

Privia Health Group has a beta of 0.76, suggesting that its share price is 24% less volatile than the broader market. Comparatively, Hinge Health has a beta of 1.19, suggesting that its share price is 19% more volatile than the broader market.

Hinge Health has a net margin of 21.02% compared to Privia Health Group's net margin of 1.43%. Hinge Health's return on equity of 66.96% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group1.43% 4.20% 2.38%
Hinge Health 21.02%66.96%19.70%

In the previous week, Hinge Health had 7 more articles in the media than Privia Health Group. MarketBeat recorded 12 mentions for Hinge Health and 5 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.83 beat Hinge Health's score of 0.68 indicating that Privia Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Hinge Health
6 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

94.5% of Privia Health Group shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by company insiders. Comparatively, 18.9% of Hinge Health shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Privia Health Group has higher revenue and earnings than Hinge Health. Hinge Health is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$2.12B1.52$22.92M$0.2697.15
Hinge Health$587.86M16.65-$528.26M$1.9661.88

Privia Health Group currently has a consensus price target of $31.20, suggesting a potential upside of 23.52%. Hinge Health has a consensus price target of $118.93, suggesting a potential downside of 1.94%. Given Privia Health Group's higher possible upside, equities analysts plainly believe Privia Health Group is more favorable than Hinge Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
Hinge Health
0 Sell rating(s)
2 Hold rating(s)
15 Buy rating(s)
2 Strong Buy rating(s)
3.00

Summary

Hinge Health beats Privia Health Group on 11 of the 17 factors compared between the two stocks.

How does Privia Health Group compare to Chemed?

Chemed (NYSE:CHE) and Privia Health Group (NASDAQ:PRVA) are both mid-cap healthcare companies, but which is the better business? We will compare the two companies based on the strength of their media sentiment, profitability, analyst recommendations, dividends, earnings, risk, valuation and institutional ownership.

Chemed presently has a consensus target price of $603.00, suggesting a potential upside of 9.60%. Privia Health Group has a consensus target price of $31.20, suggesting a potential upside of 23.52%. Given Privia Health Group's stronger consensus rating and higher probable upside, analysts clearly believe Privia Health Group is more favorable than Chemed.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Chemed
0 Sell rating(s)
4 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.43
Privia Health Group
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70

In the previous week, Privia Health Group had 2 more articles in the media than Chemed. MarketBeat recorded 5 mentions for Privia Health Group and 3 mentions for Chemed. Privia Health Group's average media sentiment score of 0.83 beat Chemed's score of 0.50 indicating that Privia Health Group is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Chemed
2 Very Positive mention(s)
0 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Chemed has a net margin of 10.61% compared to Privia Health Group's net margin of 1.43%. Chemed's return on equity of 35.18% beat Privia Health Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Chemed10.61% 35.18% 19.43%
Privia Health Group 1.43%4.20%2.38%

95.9% of Chemed shares are held by institutional investors. Comparatively, 94.5% of Privia Health Group shares are held by institutional investors. 3.3% of Chemed shares are held by insiders. Comparatively, 5.7% of Privia Health Group shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.

Chemed has a beta of 0.5, indicating that its share price is 50% less volatile than the broader market. Comparatively, Privia Health Group has a beta of 0.76, indicating that its share price is 24% less volatile than the broader market.

Chemed has higher revenue and earnings than Privia Health Group. Chemed is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Chemed$2.53B2.83$265.24M$20.9026.32
Privia Health Group$2.12B1.52$22.92M$0.2697.15

Summary

Chemed and Privia Health Group tied by winning 8 of the 16 factors compared between the two stocks.

How does Privia Health Group compare to RadNet?

Privia Health Group (NASDAQ:PRVA) and RadNet (NASDAQ:RDNT) are both mid-cap healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, media sentiment, dividends, valuation, profitability, institutional ownership, earnings and analyst recommendations.

Privia Health Group currently has a consensus target price of $31.20, indicating a potential upside of 23.52%. RadNet has a consensus target price of $89.67, indicating a potential upside of 16.62%. Given Privia Health Group's higher possible upside, equities analysts clearly believe Privia Health Group is more favorable than RadNet.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Privia Health Group
0 Sell rating(s)
3 Hold rating(s)
7 Buy rating(s)
0 Strong Buy rating(s)
2.70
RadNet
1 Sell rating(s)
1 Hold rating(s)
6 Buy rating(s)
1 Strong Buy rating(s)
2.78

94.5% of Privia Health Group shares are owned by institutional investors. Comparatively, 77.9% of RadNet shares are owned by institutional investors. 5.7% of Privia Health Group shares are owned by insiders. Comparatively, 5.1% of RadNet shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

Privia Health Group has a beta of 0.76, meaning that its share price is 24% less volatile than the broader market. Comparatively, RadNet has a beta of 1.42, meaning that its share price is 42% more volatile than the broader market.

Privia Health Group has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Privia Health Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Privia Health Group$2.12B1.52$22.92M$0.2697.15
RadNet$2.04B2.97-$18.65M-$0.29N/A

In the previous week, RadNet had 13 more articles in the media than Privia Health Group. MarketBeat recorded 18 mentions for RadNet and 5 mentions for Privia Health Group. Privia Health Group's average media sentiment score of 0.83 beat RadNet's score of 0.73 indicating that Privia Health Group is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Privia Health Group
3 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
RadNet
6 Very Positive mention(s)
5 Positive mention(s)
3 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Privia Health Group has a net margin of 1.43% compared to RadNet's net margin of -0.94%. Privia Health Group's return on equity of 4.20% beat RadNet's return on equity.

Company Net Margins Return on Equity Return on Assets
Privia Health Group1.43% 4.20% 2.38%
RadNet -0.94%3.14%1.08%

Summary

Privia Health Group beats RadNet on 11 of the 17 factors compared between the two stocks.

Get Privia Health Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for PRVA and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding PRVA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

PRVA vs. The Competition

MetricPrivia Health GroupHealthcare Providers & Services IndustryHealthcare SectorNASDAQ Exchange
Market Cap$3.23B$10.63B$7.76B$11.62B
Dividend YieldN/A2.54%2.46%4.43%
P/E Ratio97.1835.9734.2429.88
Price / Sales1.522.088.555.69
Price / Cash88.6923.3421.9322.50
Price / Book3.703.604.383.66
Net Income$22.92M$332.46M$3.52B$392.18M
7 Day Performance3.57%-3.85%-5.33%-4.12%
1 Month Performance12.08%-1.57%-4.47%-6.60%
1 Year Performance8.70%19.09%-1.40%-7.08%

Privia Health Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
PRVA
Privia Health Group
4.1374 of 5 stars
$25.24
-0.1%
$31.20
+23.6%
+7.7%$3.23B$2.12B97.181,226
FMS
Fresenius Medical Care AG & Co. KGaA
3.5759 of 5 stars
$22.75
-0.9%
$23.43
+3.0%
-6.5%$12.09B$22.20B13.141,488
DVA
DaVita
4.491 of 5 stars
$179.20
-3.4%
$235.86
+31.6%
+43.0%$11.27B$13.64B13.1978,000
HNGE
Hinge Health
2.2007 of 5 stars
$123.17
+0.8%
$118.93
-3.4%
+196.2%$9.93B$587.86M62.781,437
CHE
Chemed
3.5757 of 5 stars
$544.82
+1.3%
$603.00
+10.7%
+26.4%$7.10B$2.53B26.0815,811

Related Companies and Tools


This page (NASDAQ:PRVA) was last updated on 11/17/2026 by MarketBeat.com Staff.
From Our Partners